HOME >> BIOLOGY >> NEWS
Common Prostate Cancer: A Different Process Altogether?

"...one of the commonest cancers in men has the potential to be corrected without using typical gene therapy."

Nearly 90 percent of prostate cancers -- "the typical, garden varieties," according to Johns Hopkins scientists -- are linked to a previously unsuspected but common genetic process that could be reversible. The process looks to be a fundamental one in cancer and appears in other common forms of the disease, like breast cancer.

Unlike cancers due to mutations that make structural changes in a gene, such as the colon cancers that run in families, most prostate cancer may involve a process called "gene switching," the researchers say. Switching occurs when certain members of a family of genes are switched on while others in the family shut down. "It's a process common during embryonic development," says molecular pathologist Shrihari S. Kadkol, M.D., Ph.D., one of the researchers in a study appearing today in Nature Medicine, "but we believe this is the first time anyone's definitively linked gene switching within a family of genes, with cancer."

"Most important is that someday, it's likely we can reverse switching with drugs," says molecular pathologist Gary R. Pasternack, M.D., Ph.D., who led the Hopkins research team. "This means one of the commonest cancers in men has the potential of being corrected without using typical gene therapy."

In their work, the scientists used molecular probes to highlight and compare the gene activity in cancer patients' normal prostate tissue with that of their tumors. The investigators found clear evidence that a gene called pp32 was switched on in normal cells but generally switched off in cancer cells. Earlier studies by the team showed pp32 acts as a suppressor and keeps cells from turning malignant. Yet close relatives of the gene, to theresearchers' surprise, act like pp32's genetic evil twins and encourage tumor growth. The pp32r1 and pp32r2 genes are present and turned on
'"/>

Contact: Marjorie Centofanti
mcentofanti@jhmi.edu
410-955-8725
Johns Hopkins Medical Institutions
2-Mar-1999


Page: 1 2

Related biology news :

1. Common cold virus can cause polio in mice when injected into muscles
2. Common call for action on European Research Council (ERC)
3. Common therapy for HIV associated with cervical abnormality regression
4. Common chemicals morphing into potential toxins in Arctic
5. Common worm provides insights into salmonella virulence
6. Common virus may contribute to uncommon bone disease in children
7. Common airborne substance makes asthmatics more sensitive to house dust mites: study
8. Common genetic damages in non-dividing cells lead to the creation of mutant proteins
9. Common nutrients fed to pregnant mice altered their offsprings coat color
10. Common treatment for depression is safe and effective for Alzheimers patients
11. Common gene variant increases risk of atherosclerosis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/3/2018)... ... October 03, 2018 , ... Fit4D, ... the appointment of healthcare visionary, Jimmy Lee, as Strategic Advisor to the company’s ... of healthcare industry experience. As a Senior Executive at Anthem, he had P&L ...
(Date:10/2/2018)... ... ... a fun-loving eight-year-old Labrador retriever. Like many labs, Stuart’s favorite thing in the world ... much that whenever anyone comes to our door, he grabs a toy to greet them, ... 2017, Stuart began limping and eventually could no longer play fetch. Though he was ...
(Date:10/2/2018)... ... October 02, 2018 , ... As a leading ... Biosciences, The Cell Analysis Company , is excited to offer xCELLigence® RTCA ... design and data analysis for immune oncology researchers are now much easier, especially ...
Breaking Biology News(10 mins):
(Date:9/29/2018)... ... September 29, 2018 , ... Voxx ... early-stage companies to access the power of influence analytics and data-driven engagement decision ... a broader market that didn’t necessarily have access to the same financial resources ...
(Date:9/27/2018)... ... 2018 , ... Medable was named DPharm Idol at this ... human digitome, a digital representation of human health and disease, by removing the ... data sources. Dr. Michelle Longmire, Co-Founder and CEO of Medable, explained that their ...
(Date:9/22/2018)... ... September 20, 2018 , ... ... venture. The synergistic combination of Predicine’s GeneRADAR molecular insights platform with Flagship’s ... to empower clinical trials in the immuno-oncology (IO) space. , IO therapies ...
(Date:9/13/2018)... ... September 13, 2018 , ... Asymmetrex’s director, James ... would have gotten in medicine, if we didn’t have the means to measure the ... patients?” His answer, “Nowhere! And that is what’s holding up progress in stem ...
Breaking Biology Technology:
Cached News: